204 related articles for article (PubMed ID: 20848076)
1. [Targeted therapy of urological tumours. Experimental field or established therapeutic approach?].
Kramer MW; Krege S; Peters I; Merseburger AS; Kuczyk MA
Urologe A; 2010 Oct; 49(10):1260-5. PubMed ID: 20848076
[TBL] [Abstract][Full Text] [Related]
2. [Systemic therapy for metastatic renal cell carcinoma].
Kramer MW; Steffens S; von Klot C; Merseburger AS; Kuczyk MA
Aktuelle Urol; 2012 Jul; 43(4):265-8. PubMed ID: 22869498
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy in urologic oncology].
Deville JL
Prog Urol; 2011 Nov; 21(11):816-21. PubMed ID: 22032608
[TBL] [Abstract][Full Text] [Related]
4. [Precision oncology options in urological cancers].
Franz A; Plage H; Fendler A; Schlomm T; Kornienko K
Urologie; 2023 Jul; 62(7):696-704. PubMed ID: 37294331
[TBL] [Abstract][Full Text] [Related]
5. [Value of targeted therapies for renal cell cancer].
Merseburger AS; Kuczyk MA
Urologe A; 2008 Oct; 47(10):1303-10. PubMed ID: 18587556
[TBL] [Abstract][Full Text] [Related]
6. The rapidly evolving treatment landscape of advanced prostate, bladder, and renal cell carcinomas.
Hahn AW; Agarwal N
Cancer Treat Res Commun; 2020; 24():100190. PubMed ID: 32679555
[No Abstract] [Full Text] [Related]
7. [Chemotherapy and radiotherapy for urological cancer].
Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
[TBL] [Abstract][Full Text] [Related]
8. [Guideline for proper use of antineoplastic agents. Urologic cancer].
Akaza H; Miyanaga N
Gan To Kagaku Ryoho; 2002 Jun; 29(6):1055-64. PubMed ID: 12109446
[No Abstract] [Full Text] [Related]
9. Chemotherapy of urologic malignancies.
Scher HI; Sternberg CN
Semin Urol; 1985 Nov; 3(4):239-80. PubMed ID: 3916569
[No Abstract] [Full Text] [Related]
10. [Targeted therapy for metastatic bladder cancer].
Vom Dorp F; Börgermann C; Rose A; Becker M; Rübben H
Urologe A; 2008 Oct; 47(10):1311-4. PubMed ID: 18587555
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.
Albiges L; Choueiri T; Escudier B; Galsky M; George D; Hofmann F; Lam T; Motzer R; Mulders P; Porta C; Powles T; Sternberg C; Bex A
Eur Urol; 2015 Jan; 67(1):100-110. PubMed ID: 24841777
[TBL] [Abstract][Full Text] [Related]
12. Genitourinary malignancies.
Smith MR; Kantoff P
Cancer Chemother Biol Response Modif; 1999; 18():394-417. PubMed ID: 10800495
[No Abstract] [Full Text] [Related]
13. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Kobayashi H; Obata K
Cancer Chemother Pharmacol; 1994; 35 Suppl():S14-7. PubMed ID: 7994781
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for genitourinary tumors.
Nakayama T; Kitano S
Int J Urol; 2019 Mar; 26(3):326-333. PubMed ID: 30710374
[TBL] [Abstract][Full Text] [Related]
15. Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma: When is the revolution coming?
Santoni M; Rizzo M; Burattini L; Berardi R; Carteni G; Cascinu S
Curr Cancer Drug Targets; 2013 Mar; 13(3):313-25. PubMed ID: 23190497
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Sternberg CN; Yagoda A; Scher HI; Watson RC; Geller N; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N
Cancer; 1989 Dec; 64(12):2448-58. PubMed ID: 2819654
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y
Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580
[TBL] [Abstract][Full Text] [Related]
18. [DGFIT: Immune and targeted therapy in urologic oncology – what can be expected?].
Hegele A; Heinzer H; Rüttinger D; Siebels M
Aktuelle Urol; 2012 Jul; 43(4):219-26. PubMed ID: 23035262
[TBL] [Abstract][Full Text] [Related]
19. [What are waiting for chemotherapy in urology (author's transl)].
Benoit G; Boccon-Gibod L; Debre B; Steg A
Sem Hop; 1981 Jun 18-25; 57(25-28):1228-37. PubMed ID: 6266046
[TBL] [Abstract][Full Text] [Related]
20. [Current aspects of second-line and sequence therapy of metastatic renal cell carcinoma].
Gschwend JE
Onkologie; 2010; 33 Suppl 1():10-1. PubMed ID: 20164670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
